TrialTherapeutic advances in respiratory disease

Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studies.

Artur Bednarczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.